Entries by aaron

TN Super Speciality seat surrender matter raised in Parliament- MoS Health clarifies

New Delhi: The Medical Counselling Committee (MCC) of the Directorate General of Health Services (DGHS) has the responsibility to conduct counselling for 100% seats of super-speciality courses across the country, the Union Minister of State for Health, Smt Anupriya Patel, informed the Lok Sabha. MoS Health clarified that the Supreme Court has granted a 50% reservation […]

JIPMER launches Capacity Building Unit under Mission Karmayogi Initiative

Puducherry: The Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER) Puducherry has officially joined the Government of India’s flagship initiative – Mission Karmayogi, by establishing its own Capacity Building Unit (CBU).  This step aligns with the directives of the Capacity Building Commission (CBC) and the Department of Personnel and Training (DoPT), Government of India. […]

Mounjaro, Wegovy sales in India double on month in July

Hyderabad: Sales of weight-loss drugs Wegovy by Danish pharmaceutical giant Novo Nordisk and Mounjaro by U.S.-based Eli Lilly doubled in India in July from a month earlier, according to data from research firm Pharmarack. The surge reflects rapidly growing demand for these blockbuster anti-obesity treatments in the world’s most populous country,. Wegovy, which was launched locally […]

Eli Lilly Gets CDSCO Panel Nod for Ixekizumab Safety Label Update

New Delhi: Eli Lilly and Company (India) Pvt Ltd has secured regulatory clearance from the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) for updating the package insert of its drug Ixekizumab Solution for Injection 80 mg/mL, in both pre-filled autoinjector and pre-filled syringe formats. The approval pertains to Package Insert […]

CDSCO Panel Approves New Indications for Novo Nordisk’s Semaglutide, Mandates PMS Study

New Delhi: Recommending to conduct post marketing surveillance (PMS) study in India, the Subject Expert Committee (SEC) functional under the Central Drugs Standard Control Organization (CDSCO) has granted approval to the drug major Novo Nordisk India for the additional indication of the drug Semaglutide Injection 0.25 mg, 0.5 mg, and 1 mg. The additional indications […]

ESIC Medical College Hospital Chennai unveils Rs 4.03 crore Cath Lab facility

Chennai: ESIC Medical College and Hospital, KK Nagar, Chennai, marked a significant milestone in its journey towards enhanced healthcare delivery with the inauguration of the Cath Lab services.  This facility is set to significantly improve cardiac diagnostic and interventional services for ESI beneficiaries in the region. The inauguration ceremony was presided over by Shri Ashok […]

Intas Pharma Gets Expert Panel Nod For PMS Data On Tofacitinib Ointment In Atopic Dermatitis

New Delhi: Intas Pharma has received approval from the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) for the results of its Post-Marketing Surveillance (PMS) study on Tofacitinib 2% w/w ointment in adult patients with mild to moderate atopic dermatitis, including those experiencing flare-ups. The update was discussed during the SEC’s […]

CM Siddaramaiah pays surprise visit to Victoria Hospital, calls for expansion

Bengaluru: Karnataka Chief Minister Siddaramaiah pays a surprise visit to the government-run Victoria Hospital on Wednesday. He stressed the urgent need to expand the capacity of the hospital, amid the growing number of patients arriving from across the country. He paid a surprise visit to the hospital along with Medical Education Minister Sharan Prakash Patil […]

Walking Faster and Farther Reduces CV Risk among People with High Blood Pressure: Study

Analysis of over 36,000 people with high blood pressure has shown that taking more steps, even below the recommended daily target of 10,000 steps, and walking faster, is associated with a significant reduction in the risk of major problems of the heart and blood vessels. The study, published in the European Journal of Preventive Cardiology, […]

CGM Metrics Strongly Predict 5-Year Mortality Risk in Diabetes, Study Shows

USA: A new long-term analysis published in Diabetes Care has highlighted the potential of continuous glucose monitoring (CGM) metrics to predict the risk of death among individuals with type 1 or type 2 diabetes. The study, led by Tomoki Okuno from the Department of Biostatistics at the University of California, Los Angeles, in collaboration with […]